A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer

Abstract excerpt

PURPOSE: Non-small-cell lung cancer (NSCLC) is a tumor in which only small improvements in clinical outcome have been achieved. The issue is critical for stage I patients for whom there are no available biomarkers that indicate which high-risk patients should receive adjuvant chemotherapy. We aimed to find DNA methylation markers that could be helpful in this regard. PATIENTS AND METHODS: A DNA methylation...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Epigenetics and DNA Methylation
• Share to Lung Cancer Diagnosis and Treatment
• Share to Lung Cancer Treatments and Mutations